Search research articles
Contact Us
Filters
Showing results (1-10 of 121) with videos related to
Page
of 13
Sort By:
Journal of Neurochemistry
|
July 20, 2001
Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases
E Junn, M M Mouradian
Experimental Neurology
|
March 1, 1997
Gene therapy for Parkinson's disease: an approach to the prevention or palliation of levodopa-associated motor complications
M M Mouradian, T N Chase
Brain Research
|
February 13, 1989
Decrease in a proenkephalin peptide in cerebrospinal fluid in Huntington's disease and progressive supranuclear palsy
M J Iadarola, M M Mouradian
Gene Therapy
|
June 1, 1997
Gene therapy for Parkinson's disease: current knowledge and future perspective
M M Mouradian, T N Chase
Clinical Neuropharmacology
|
August 1, 1988
Central mechanisms and levodopa response fluctuations in Parkinson's disease
M M Mouradian, T N Chase
Molecular and Cellular Endocrinology
|
December 28, 1999
Up-regulation of D1A dopamine receptor gene transcription by estrogen
S H Lee, M M Mouradian
Journal of Neurochemistry
|
February 1, 1993
Protection against acute MPTP-induced dopamine depletion in mice by adenosine A1 agonist
Y S Lau, M M Mouradian
Molecular and Cellular Endocrinology
|
November 1, 1993
Characterization of a corticotropin releasing hormone responsive region in the murine proopiomelanocortin gene
J F Bishop, M M Mouradian
Biochemistry
|
September 15, 1992
Analysis of the promoter region of the rat D2 dopamine receptor gene
T Minowa, M T Minowa, M M Mouradian
The Journal of Biological Chemistry
|
November 5, 1993
Activator region analysis of the human D1A dopamine receptor gene
M T Minowa, T Minowa, M M Mouradian
Page
of 13
Search research articles
Search
Showing results (1-10 of 121) with videos related to
Sort By:
Page
of 13
Journal of Neurochemistry
|
July 20, 2001
Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases
E Junn, M M Mouradian
Experimental Neurology
|
March 1, 1997
Gene therapy for Parkinson's disease: an approach to the prevention or palliation of levodopa-associated motor complications
M M Mouradian, T N Chase
Brain Research
|
February 13, 1989
Decrease in a proenkephalin peptide in cerebrospinal fluid in Huntington's disease and progressive supranuclear palsy
M J Iadarola, M M Mouradian
Gene Therapy
|
June 1, 1997
Gene therapy for Parkinson's disease: current knowledge and future perspective
M M Mouradian, T N Chase
Clinical Neuropharmacology
|
August 1, 1988
Central mechanisms and levodopa response fluctuations in Parkinson's disease
M M Mouradian, T N Chase
Molecular and Cellular Endocrinology
|
December 28, 1999
Up-regulation of D1A dopamine receptor gene transcription by estrogen
S H Lee, M M Mouradian
Journal of Neurochemistry
|
February 1, 1993
Protection against acute MPTP-induced dopamine depletion in mice by adenosine A1 agonist
Y S Lau, M M Mouradian
Molecular and Cellular Endocrinology
|
November 1, 1993
Characterization of a corticotropin releasing hormone responsive region in the murine proopiomelanocortin gene
J F Bishop, M M Mouradian
Biochemistry
|
September 15, 1992
Analysis of the promoter region of the rat D2 dopamine receptor gene
T Minowa, M T Minowa, M M Mouradian
The Journal of Biological Chemistry
|
November 5, 1993
Activator region analysis of the human D1A dopamine receptor gene
M T Minowa, T Minowa, M M Mouradian
Page
of 13